|Articles|March 12, 2008
Franz B. Humer Steps Down as CEO of Roche
Author(s)BioPharm International Editors
Franz B. Humer has stepped down as chief executive officer (CEO) of the Roche Group (Basel, Switzerland), after holding that title for 10 years.
Advertisement
Franz B. Humer has stepped down as chief executive officer (CEO) of the Roche Group (Basel, Switzerland), after holding that title for 10 years. Humer is being succeeded by Severin Schwan, who is the former CEO of Roche Diagnostics.
Roche news
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
2
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
3
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
4
Why Radiopharmaceuticals Are Ideal for Treating Cancer
5
